AEON Biopharma, Inc., headquartered in Newport Beach, California, is an innovative biopharmaceutical company focused on the development of advanced botulinum toxin products for various debilitating medical conditions. With a strong emphasis on proprietary formulations, AEON is well-positioned in the neuromodulators market, leveraging its robust pipeline to enhance treatment options and improve patient outcomes. The company is poised to capitalize on the increasing demand for effective therapeutic and aesthetic interventions, solidifying its role as a key player in the biopharmaceutical industry.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

5 PARK PLAZA, IRVINE, CA, UNITED STATES, 92614

December

$10.9 Million

-$17.9 Million

0.0

-13.91

$0.00

0.0%

0.753